Rodríguez PA, Ríos DA, Chaves PI; Estrada VJ

Language: Spanish
References: 12
Page: 221-228
PDF size: 137.13 Kb.

ABSTRACT

Introduction: serous retinal detachment causes visual acuity decrease due to the passage of fluid from the choroid into the subretinal space. This disease has several causes including idiopathic, congenital, postoperative, and secondary to infectious uveitis, autoimmune, vascular, hematological and neoplastic ones.
Objective: to describe an unusual case of a young patient with serous retinal detachment associated with discoid fixed lupus and nephropathy by immunoglobulin A with satisfactory response to steroids use.
Clinical case: a male patient of 18 years old was presented in the retina office of the Ophthalmological Center at the University Hospital Manuel Ascunce Domenech with sudden decrease of visual acuity in both eyes with an initial diagnosis of serous central choroidopathy, which later progressed into bilateral serous detachments with entire posterior pole involvement. By his antecedents, a specialty consultation in dermatology and nephrology was carried out, deciding to initiate treatment with high-dose steroids, intravenous vitamin therapy, and anti-inflammatory and topical cycloplegic mydriatic with excellent response to therapy.

REFERENCES

1. Anand R, Tasman WS, McNamara JA. Desprendimiento de retina no regmatógeno. En: Ryan SJ, editor. Retina. Filadelfia: Elservier Inc; 2009.p.894-910.

2. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestaciones del Lupus Eritematoso sistémico. Reumatología. 2007; (46):1757-62.

3. Hernández da Mato S, Cornejo Ballestero R, Maraña Samora L. Desprendimiento de retina traccional secundario a vasculitis oclusiva por síndrome antifosfolipidos. Caso clínico. Rev Mex Oftalmología. 2009 mar-abr; 83(2):119-22.

4. Scott J, Daré A, Franco RF. Hemiretian vein occlusion associated with membranous glomerulonephritis. Am J ophthalmol. 2008; 133(3):415-6.

5. Eguias Martínez F, Ríos Torres M, Capote Cabrera A. Manual de tratamiento y diagnóstico en oftalmología. La Habana: Editorial Ciencias Médicas; 2009.

6. Goméz Ulla de Irazazábal F, Suárez de Figueroa M, Nadal Reus J. Casos clínicos en retina y Vitreos. Premios 2010. Barcelona: Editorial Glosa; 2010.

7. Font J, Khamashata M, Vilardell M. Lupus eritematoso sistémico. 2da ed. Barcelona: MRA ediciones; 2002.

8. Cunningham ET, Alfred PR, Irvine AR. Central serous chorioretinopathy in patiens with systemic lupus erythematosus. Ophthalmology. 2006; 103:2081-90.

9. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 2007; (79):922-5.

10. Barbón García JJ, Álvarez Suárez ML, Álvarez Navascués R, Viña Escalar C, Querediaga Madariaga J. Desprendimientos serosos retinianos asociados a corticoterapia en un lupus eritematoso sistémico. Arch Soc Esp Oftalmol. 2008; (79):177-80.

11. Jabs DA. Ocular manifestations of the rheumatic diseases. In: Jabs DA, editor Duane´s Ophthalmology on CD-ROM. St Louis: Lippincott, Williams & Wilkins; 2003.p.516-38.

12. Ríos Torres M, Capote Cabrera A, Hernández Silva R, Eguias Martínez F, Padilla González C. Oftalmología .Criterios y tendencias actuales. La Habana: Editorial Ciencias Médica; 2009.